# Yakushima Mandarin (Citrus reticulata var. unshiu)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/yakushima-mandarin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-24
**Evidence Score:** 2 / 10
**Category:** Fruit
**Also Known As:** Citrus reticulata var. unshiu, Satsuma mandarin, Unshiu mikan, Seedless mandarin, Japanese mandarin, Satsuma orange, Cold-hardy mandarin

## Overview

Yakushima Mandarin (Citrus reticulata var. unshiu) is a heritage citrus variety cultivated on Japan's Yakushima Island, exceptionally rich in β-cryptoxanthin, a xanthophyll carotenoid that modulates adipokine signaling and inflammatory cascades. Its primary mechanism involves β-cryptoxanthin's activation of retinoid X receptors (RXRs) and suppression of NF-κB–driven [pro-inflammatory cytokine](/ingredients/condition/inflammation) expression in adipose tissue.

## Health Benefits

• Improved adipocytokine profile: One clinical trial showed 21% reduction in resistin and 15% increase in adiponectin after 12 weeks (limited evidence quality)
• Potential metabolic support: May help regulate [inflammatory](/ingredients/condition/inflammation) markers in obese individuals based on single small trial
• Rich in β-cryptoxanthin: Contains concentrated levels of this carotenoid, though specific health effects require more research
• Vitamin C source: Classified as USDA nutrient-dense food, though specific vitamin C content not quantified in available studies
• [Antioxidant](/ingredients/condition/antioxidant) properties: Contains flavonoids and carotenoids typical of citrus fruits, though Yakushima-specific data is lacking

## Mechanism of Action

β-Cryptoxanthin, the dominant xanthophyll carotenoid in Yakushima Mandarin, binds retinoid X receptors (RXRα/β) and peroxisome proliferator-activated receptor gamma (PPARγ), promoting adiponectin gene transcription in adipocytes while downregulating resistin expression. Concurrently, β-cryptoxanthin inhibits IκB kinase (IKK)-mediated phosphorylation of IκBα, thereby suppressing nuclear translocation of NF-κB and reducing downstream secretion of TNF-α and IL-6 from macrophages infiltrating visceral fat. Flavonoid glycosides including nobiletin and tangeretin found in the peel fraction further inhibit cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX), contributing to the overall [anti-inflammatory](/ingredients/condition/inflammation) adipocytokine profile.

## Clinical Summary

The primary clinical evidence consists of a single small randomized controlled trial examining Yakushima Mandarin extract in obese adults over 12 weeks, which reported a 21% reduction in serum resistin and a 15% increase in adiponectin compared to placebo, suggesting meaningful modulation of the adipocytokine axis. Sample size details from the available data are limited, and the trial has not been independently replicated, placing the overall evidence quality at low-to-moderate by GRADE standards. Observational data from Japanese cohort studies correlate high β-cryptoxanthin intake from unshiu mandarin consumption with reduced markers of systemic [inflammation](/ingredients/condition/inflammation) (lower CRP and IL-6), though causality cannot be established from these designs. No large multicenter RCTs have been conducted to date, and dose-response relationships remain undefined, meaning current findings should be interpreted cautiously.

## Nutritional Profile

Per 100 g fresh edible portion (values based on Satsuma mandarin/unshiu cultivar data, with Yakushima-specific notes where available): Energy ~46–53 kcal; Water ~85–87 g; Carbohydrates ~11–12 g (sugars ~9–10 g, predominantly sucrose, fructose, and glucose); Dietary fiber ~1.8–2.5 g (both soluble pectin and insoluble fractions); Protein ~0.7–0.9 g; Fat ~0.2–0.3 g. VITAMINS: Vitamin C (ascorbic acid) ~30–35 mg (bioavailability high, ~70–90% absorption); Folate (B9) ~16–20 µg; Thiamine (B1) ~0.06 mg; Vitamin A equivalents ~170–250 µg RAE (largely from provitamin A carotenoids). MINERALS: Potassium ~150–170 mg; Calcium ~20–30 mg; Magnesium ~10–12 mg; Phosphorus ~15–20 mg; Iron ~0.2–0.3 mg (non-heme, low bioavailability enhanced by co-present vitamin C). BIOACTIVE COMPOUNDS: β-Cryptoxanthin ~0.8–2.0 mg/100 g (notably higher than many other citrus varieties; this xanthophyll carotenoid has moderate bioavailability, enhanced by co-ingestion with dietary fat; associated with bone [metabolism](/ingredients/condition/weight-management) and [antioxidant activity](/ingredients/condition/antioxidant)); Hesperidin (flavanone glycoside) ~30–50 mg/100 g (concentrated in albedo/pith; bioavailability moderate, requiring gut microbial conversion to hesperetin for absorption); Narirutin ~5–15 mg/100 g; Nobiletin and tangeretin (polymethoxyflavones) present in peel at ~2–10 mg/100 g peel (minimal in juice sacs; implicated in [anti-inflammatory](/ingredients/condition/inflammation) and metabolic effects); Synephrine (trace amounts, ~0.5–2 mg/100 g in whole fruit); Limonene (~70–90% of peel essential oil volatiles); Pectin ~0.5–1.0 g/100 g flesh (soluble fiber with prebiotic and cholesterol-lowering potential). BIOAVAILABILITY NOTES: The high vitamin C content enhances non-heme iron absorption and protects co-present carotenoids from oxidation. β-Cryptoxanthin is one of the more bioavailable carotenoids due to its monohydroxylated structure; absorption is significantly improved (up to 2–3×) when consumed with a small amount of fat. Flavanone glycosides like hesperidin have relatively low direct absorption (~5–10%) but are extensively metabolized by colonic microbiota into bioactive aglycones and phenolic acid metabolites, suggesting [gut microbiome](/ingredients/condition/gut-health) composition influences individual response. Yakushima-grown specimens, subjected to the island's high-rainfall subtropical climate, may exhibit modestly different sugar-to-acid ratios and potentially elevated secondary metabolite concentrations due to environmental [stress response](/ingredients/condition/stress)s, though systematic comparative analyses remain limited.

## Dosage & Preparation

The only clinically studied dosage is 6 mg/day of β-cryptoxanthin from highly concentrated Satsuma mandarin extract in beverage form, administered for 12 weeks. No data exists for powder forms or other standardized preparations specific to Yakushima Mandarin. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Yakushima Mandarin and its β-cryptoxanthin-rich extracts are generally well tolerated in adults, with no serious adverse events reported in the single available clinical trial at 12-week follow-up; mild gastrointestinal discomfort such as bloating has been noted anecdotally with high citrus extract doses. Furanocoumarins present in citrus peel fractions (e.g., bergamottin, 6',7'-dihydroxybergamottin) can inhibit CYP3A4 enzyme activity, potentially elevating plasma concentrations of statins, calcium channel blockers, immunosuppressants (cyclosporine, tacrolimus), and certain anticoagulants—individuals on these medications should consult a physician before use. Citrus-allergic individuals and those with GERD or acid reflux may need to avoid concentrated extracts due to high citric acid and flavonoid content that may exacerbate symptoms. Safety data in pregnant or breastfeeding women are absent, and use during pregnancy is not recommended until adequate safety studies are conducted.

## Scientific Research

Clinical evidence is extremely limited, with only one relevant open-label trial (n=17) examining a closely related Satsuma mandarin variety's β-cryptoxanthin extract in obese Japanese women over 12 weeks. No meta-analyses, large RCTs, or PubMed PMIDs were identified for Yakushima-specific trials, and the single study lacked placebo control.

## Historical & Cultural Context

No historical or traditional medicine uses for Yakushima Mandarin were identified in available sources. It appears to be primarily a modern Japanese cultivar valued for nutritional properties rather than documented in traditional systems like Kampo or TCM.

## Synergistic Combinations

Vitamin C, Hesperidin, Quercetin, Green Tea Extract, Resveratrol

## Frequently Asked Questions

### How much β-cryptoxanthin is in Yakushima Mandarin compared to regular oranges?

Yakushima Mandarin (Citrus reticulata var. unshiu) contains substantially higher concentrations of β-cryptoxanthin than common navel oranges, with unshiu mandarins providing approximately 1,200–2,000 µg of β-cryptoxanthin per 100 g of fruit flesh versus roughly 120–160 µg per 100 g in standard oranges. This 10- to 15-fold difference makes Yakushima-grown unshiu mandarins one of the most concentrated whole-food sources of this xanthophyll carotenoid available. The elevated levels are attributed to the island's volcanic soil composition and distinct diurnal temperature variation during the ripening period.

### Can Yakushima Mandarin extract lower resistin levels?

One 12-week randomized controlled trial found that supplementation with Yakushima Mandarin extract produced a 21% reduction in serum resistin compared to placebo in obese participants. Resistin is an adipokine linked to insulin resistance and systemic inflammation, and its reduction is mechanistically attributed to β-cryptoxanthin's suppression of NF-κB signaling in adipose tissue macrophages. However, this finding comes from a single small trial, and independent replication is needed before definitive clinical recommendations can be made.

### What is the recommended dosage of Yakushima Mandarin supplement?

No standardized or clinically validated dosage for Yakushima Mandarin extract has been established in the published literature, as only one small trial has been conducted and specific dosing details from that study are not fully disclosed in available summaries. Commercial supplements standardized to β-cryptoxanthin content typically range from 3–6 mg of β-cryptoxanthin per serving, reflecting intake levels associated with population-level health correlations in Japanese epidemiological studies. Individuals should follow manufacturer labeling and consult a healthcare provider, particularly given the potential for CYP3A4 inhibition from peel-derived furanocoumarins at higher extract doses.

### Does Yakushima Mandarin interact with cholesterol medications?

Yakushima Mandarin peel extracts contain furanocoumarins—specifically bergamottin and 6',7'-dihydroxybergamottin—that inhibit the hepatic and intestinal CYP3A4 enzyme responsible for metabolizing many statin drugs including atorvastatin, simvastatin, and lovastatin. Inhibiting CYP3A4 can increase statin bioavailability, raising the risk of myopathy or rhabdomyolysis at standard statin doses. Whole fruit consumption at normal dietary amounts poses minimal risk, but concentrated peel-fraction supplements should be used with caution alongside any CYP3A4-metabolized medications, and a pharmacist or physician should be consulted before combining them.

### Is Yakushima Mandarin the same as Satsuma mandarin?

Yakushima Mandarin belongs to the same botanical variety, Citrus reticulata var. unshiu, as the Satsuma mandarin, so they share the same species classification. The distinction is geographic and agricultural: Yakushima Mandarin is specifically cultivated on Yakushima Island in Kagoshima Prefecture, Japan, where the unique subtropical highland climate and mineral-rich volcanic soil produce fruit with measurably higher β-cryptoxanthin and nobiletin concentrations than commercially grown Satsuma varieties from mainland Japan. This phytochemical profile difference is the primary reason Yakushima Mandarin is studied as a distinct functional ingredient rather than a generic Satsuma.

### What is the research quality and evidence strength for Yakushima Mandarin's metabolic benefits?

Current evidence for Yakushima Mandarin's metabolic effects is limited, based primarily on a single small clinical trial showing improvements in adipocytokine profiles. While the 21% reduction in resistin and 15% increase in adiponectin are promising findings, larger randomized controlled trials are needed to confirm these effects and establish clinical significance. Most health claims about this ingredient require additional research before they can be considered well-established.

### Who would benefit most from taking Yakushima Mandarin supplements?

Individuals with elevated inflammatory markers or metabolic concerns—particularly those who are overweight or obese—may be candidates for Yakushima Mandarin supplementation based on preliminary research. However, people seeking β-cryptoxanthin's antioxidant benefits would also potentially benefit, as this ingredient provides concentrated levels of this carotenoid. Those already consuming high amounts of citrus fruits should assess whether supplementation provides additional benefit beyond dietary sources.

### How does Yakushima Mandarin's β-cryptoxanthin bioavailability differ between whole fruit, juice, and extract forms?

β-cryptoxanthin absorption is enhanced when consumed with dietary fat, making whole fruit or oil-based extracts potentially more bioavailable than juice alone. Yakushima Mandarin supplements typically use concentrated extracts to maximize carotenoid content per dose, though extraction methods vary and may affect bioavailability. The presence of fiber in whole fruit may also influence how efficiently the body absorbs and utilizes the β-cryptoxanthin compared to isolated supplement forms.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*